Trials / Completed
CompletedNCT00262249
Effect of Growth Hormone in Children With Growth Hormone Deficiency
Effect of Growth Hormone in Children With Growth Hormone Deficiency and Idiopathic Short Stature
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 173 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 3 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in the United States of America (USA). The purpose of the trial is to compare the effect of Norditropin® using different dosing regimens in children suspected of growth hormone deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin |
Timeline
- Start date
- 2000-08-01
- Primary completion
- 2004-05-01
- Completion
- 2004-05-01
- First posted
- 2005-12-06
- Last updated
- 2017-01-18
Locations
40 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00262249. Inclusion in this directory is not an endorsement.